Scope of the Molecular Diagnostic Market gives the complete details of Competitive Landscape, Market Share Analysis, Drivers, Restraints, Trends, Partnerships, SWOT Comparison, Key Opportunities and major companies profile.
Pune, India (PRWEB) September 04, 2015
Research report ‘Molecular Diagnostics in Cancer Testing’ says Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. Complete report available at http://www.rnrmarketresearch.com/molecular-diagnostics-in-cancer-testing-market-report.html.
Molecular Diagnostics in Cancer Testing report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide. Order a copy of this research report at http://www.rnrmarketresearch.com/molecular-diagnostics-in-cancer-testing-market-report.html.
‘Molecular Diagnostics in Infectious Disease Testing’ describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in the blood--has led to this revolutionary market development. Specifically, molecular diagnostics offers the power of advanced analytical techniques to diagnose infectious diseases. Whereas before, the detection of many infectious agents was slow and expensive due to reliance upon culturing methods, researchers are now at the cusp of overcoming such limitations via the use of nucleic acid-mediated molecular diagnostics testing. Complete report available at http://www.rnrmarketresearch.com/molecular-diagnostics-in-infectious-disease-testing-market-report.html.
The purpose of this report is to describe the emerging field of molecular diagnostics in infectious disease testing. The infectious disease space is the most dominant and profitable sector of molecular diagnostics. Topics covered in this study include: 1) the existing and emerging technologies in the field, 2) the U.S. and global market size for molecular diagnostic products and 3) the profiles of companies that are focusing on the molecular diagnostic sector. The research examines drivers and restraints for sales growth, market share and technical trends. In addition, an in-depth analysis of the competitive situation of prominent market venders is provided with five-year sales forecasts. Order a copy of ‘Molecular Diagnostics in Infectious Disease Testing’ research report at http://www.rnrmarketresearch.com/molecular-diagnostics-in-infectious-disease-testing-market-report.html .
‘Molecular Diagnostics in Genetic Testing’ is a No 2013 publication of 185 pages and it says Molecular diagnostics in genetic testing brings advanced analytical techniques to the diagnosis and treatment of genetic disorders. This report describes the emerging field of molecular diagnostics in genetic testing. This review analyzes the size and growth of the molecular diagnostics in genetic testing market, including the factors that influence the various market segments within it and the dollar volume of sales, both in the United States and worldwide. Moreover, this analysis profiles the leading companies focused on the molecular diagnostics for genetic testing sector. Companies profiled in this research report are Abbott Laboratories, Beckman Coulter, CombiMatrix, EntroGen Inc, Genmark Diagnostics Inc, Genomic Health, Hologic Inc, llumina Inc, IntegenX, Laboratory Corporation of America Holdings, Life Technologies Corporation, Luminex Corporation, Myriad Genetics Inc, Natera, NetBio, PerkinElmer Genetics, Progenika Inc, Roche Diagnostics, Sequenom Inc, Signature Genomics, Spartan Bioscience Inc, and Transgenomic Inc. Complete report available at http://www.rnrmarketresearch.com/molecular-diagnostics-in-genetic-testing-market-report.html .
Browse more reports on ‘Molecular Diagnostics Market’ at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/in-vitro-diagnostics-ivd/molecular-diagnostics.
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
UNIT no 802, Tower no. 7, SEZ
Magarpatta City, Hadapsar
Pune - 411013
+ 1 888 391 5441